Page last updated: 2024-09-02

acetylleucyl-leucyl-norleucinal and Adenocarcinoma

acetylleucyl-leucyl-norleucinal has been researched along with Adenocarcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Du, RL; Jin, BX; Li, SZ; Liu, WB; Liu, Y; Song, Y; Zhang, HH; Zhang, XD1
Banks, L; Mantovani, F1

Other Studies

2 other study(ies) available for acetylleucyl-leucyl-norleucinal and Adenocarcinoma

ArticleYear
UbcH10 overexpression increases carcinogenesis and blocks ALLN susceptibility in colorectal cancer.
    Scientific reports, 2014, Nov-07, Volume: 4

    Topics: Adenocarcinoma; Animals; Carcinogenesis; Caspases; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cyclins; Dependovirus; Female; Gene Expression Regulation, Neoplastic; Genetic Vectors; Humans; Leupeptins; Mice; Mice, Knockout; Mice, Nude; Signal Transduction; Ubiquitin; Ubiquitin-Conjugating Enzymes; Xenograft Model Antitumor Assays

2014
Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines.
    Oncogene, 1999, Jun-03, Volume: 18, Issue:22

    Topics: Acetylcysteine; Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma; Cell Nucleus; Cysteine Proteinase Inhibitors; DNA Damage; DNA-Binding Proteins; Female; Fibrosarcoma; Humans; Leupeptins; Mitomycin; Oncogene Proteins, Viral; Papillomaviridae; Polymorphism, Genetic; Repressor Proteins; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms

1999